Thursday, August 25, 2016

Targeted Breast Cancer Medical Treatment Now A Reality – MINDACT is Out!

This IS the Biggest News in Breast Cancer Management in 2016!!! 

From now on, if a woman is being offered chemotherapy for early breast cancer, she needs to check to see if she is eligible to have MammaPrint genomic testing - which has now shown a 46% reduction in the need for chemotherapy in those women who return a low risk MammaPrint test! 

As of today, the world of breast cancer management has changed forever, with the prospectively randomised proven introduction of MammaPrint testing!

Read full details here:

No comments:

Post a Comment